EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left Ventricular Transthyretin Amyloid Load and Apical Sparing in Patients with Newly Confirmed Transthyretin Amyloid Cardiomyopathy

Thomas Krammer, Maria J Baier, Vanessa Lutz, Anna-Christina Hübner, Tilman Zschiedrich, David Lukas, Christian Le Phu, Matthias Wolf, Claire Maassen, Michael Wester, Stefan Neef, Christian Schach und 10 weitere

European Journal of Heart Failure · 01.12.2025 · 27 (12) · 2979-2989

DOI: 10.1002/ejhf.70077 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 30.10.2025. Verfasst von Thomas Krammer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Heart Ventricles, Cardiomyopathies, Myocardium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reform program Faculty of Medicine, University of Regensburg, Else Kröner-Fresenius-Stiftung, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Transthyretin amyloid cardiomyopathy (ATTR-CM) is marked by deposition of transthyretin amyloid in the myocardium. Patients present with symptoms of heart failure, left ventricular (LV) hypertrophy, diastolic dysfunction, and arrhythmias. Echocardiographic apical sparing, quantified via the relative apical sparing (RELAPS) pattern, is a hallmark imaging feature but its histopathological and clinical implications remain uncertain. This study investigated the association between apical sparing, myocardial amyloid load, and clinical phenotypes in newly diagnosed ATTR-CM. Methods and results We prospectively enrolled 61 patients undergoing LV endomyocardial biopsy for suspected amyloidosis between May 2022 and May 2024. After histological confirmation, 56 patients with wild-type ATTR-CM were included. LV amyloid load was quantified from Congo red-stained endomyocardial biopsies. Echocardiographic parameters including global longitudinal strain (GLS) and RELAPS were assessed peri-interventionally. Clinical, laboratory, and imaging features were compared between patients with and without RELAPS. Patients with RELAPS had significantly higher LV amyloid load than those without. RELAPS was associated with elevated N-terminal pro-B-type natriuretic peptide levels, higher Perugini scores, lower GLS and atrial strain. No differences between patients with and without RELAPS were found regarding age or wall thickness. RELAPS correlated with markers of disease severity and atrial remodelling. The Perugini scores failed to distinguish intermediate levels of myocardial amyloid content in 71.1% of cases.

Conclusions

Apical sparing reflects advanced myocardial involvement in ATTR-CM and correlates with increased amyloid load and biomarkers in a large endomyocardial biopsy collective. RELAPS, together with histological amyloid quantification, offers valuable insights for risk stratification and may guide therapeutic intervention in this progressive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialHeart VentriclesCardiomyopathiesMyocardiumPrealbuminAmyloidHumansFemaleMaleProspective StudiesAgedEchocardiographyMiddle AgedBiopsy

Stichwörter der Autor:innen

ATTRAmyloidosisAmyloid loadApical sparingPerugini scoreTransthyretin amyloid cardiomyopathy

Substanzen

PrealbuminAmyloid

Autor:innen und Institutionen

  • Department of Internal Medicine II, University Medical Center Regensburg, Regensburg, Germany.
  • Institute for Pathology, University of Regensburg, Regensburg, Germany.
  • Institute for Pathology, University of Kiel, Kiel, Germany.
  • Department of Pharmacology, University of Regensburg, Regensburg, Germany.

Förderung

  • Reform program Faculty of Medicine, University of Regensburg
  • Else Kröner-Fresenius-Stiftung
  • Deutsche Forschungsgemeinschaft
  • HORIZON EUROPE Framework Programme
  • Else Kröner-Fresenius Stiftung: TALENT
  • Deutsche Herzstiftung

Zitieren

APA

Krammer, T., Baier, M. J., Lutz, V., Hübner, A. C., Zschiedrich, T., Lukas, D., Le Phu, C., Wolf, M., Maassen, C., Wester, M., Neef, S., Schach, C., Sag, C. M., Evert, K., Paulus, M., Meindl, C., Tafelmeier, M., Debl, K., Maier, L. S., …, & Mustroph, J. (2025). Left Ventricular Transthyretin Amyloid Load and Apical Sparing in Patients with Newly Confirmed Transthyretin Amyloid Cardiomyopathy. European Journal of Heart Failure, 27(12), 2979-2989. https://doi.org/10.1002/ejhf.70077

Vancouver

Krammer T, Baier MJ, Lutz V, Hübner AC, Zschiedrich T, Lukas D, et al. Left Ventricular Transthyretin Amyloid Load and Apical Sparing in Patients with Newly Confirmed Transthyretin Amyloid Cardiomyopathy. European Journal of Heart Failure. 2025;27(12):2979-2989. doi:10.1002/ejhf.70077

BibTeX
@article{Krammer2025,
  author = {Krammer, Thomas and Baier, Maria J and Lutz, Vanessa and Hübner, Anna-Christina and Zschiedrich, Tilman and Lukas, David and Le Phu, Christian and Wolf, Matthias and Maassen, Claire and Wester, Michael and Neef, Stefan and Schach, Christian and Sag, Can-Martin and Evert, Katja and Paulus, Michael and Meindl, Christine and Tafelmeier, Maria and Debl, Kurt and Maier, Lars S and Wagner, Stefan and Röcken, Christoph and Mustroph, Julian},
  title = {Left Ventricular Transthyretin Amyloid Load and Apical Sparing in Patients with Newly Confirmed Transthyretin Amyloid Cardiomyopathy},
  journal = {European Journal of Heart Failure},
  year = {2025},
  volume = {27},
  number = {12},
  pages = {2979--2989},
  doi = {10.1002/ejhf.70077}
}
Kostenlos starten →